Whalen Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$311K Hold
1,064
0.17% 151
2025
Q4
$373K Hold
1,064
0.2% 145
2025
Q3
$344K Sell
1,064
-2,554
-71% -$794K 0.2% 119
2025
Q2
$1.41M Buy
3,618
+2,554
+240% +$1.03M 0.88% 24
2025
Q1
$463K Hold
1,064
0.31% 66
2024
Q4
$393K Hold
1,064
0.27% 80
2024
Q3
$553K Hold
1,064
0.39% 59
2024
Q2
$577K Hold
1,064
0.46% 49
2024
Q1
$552K Hold
1,064
0.41% 41
2023
Q4
$502K Buy
+1,064
New +$492K 0.45% 58

Other funds holding ELV

Whalen Wealth Management's ELV Position: Q1 2026 in Review

Whalen Wealth Management held its Elevance Health (ELV) position steady in Q1 2026 at 1,064 shares worth $311K. The position accounts for 0.17% of the portfolio, ranked #151.

Whalen Wealth Management first reported a position in ELV in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.41M in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Whalen Wealth Management held 1,064 shares of Elevance Health worth $311K as of Q1 2026.
  • Whalen Wealth Management left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up 0.17% of Whalen Wealth Management's portfolio in Q1 2026, its #151 holding.
  • Whalen Wealth Management first reported a position in Elevance Health in Q4 2023 and has held it in 10 quarters since.
  • Whalen Wealth Management's Elevance Health position peaked at $1.41M in Q2 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Whalen Wealth Management's 13F filing for Q1 2026, filed 13 Apr 2026.